These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
404 related articles for article (PubMed ID: 33801813)
1. Medically Important Alterations in Transport Function and Trafficking of ABCG2. Homolya L Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33801813 [TBL] [Abstract][Full Text] [Related]
2. Identification of Two Dysfunctional Variants in the ABCG2 Urate Transporter Associated with Pediatric-Onset of Familial Hyperuricemia and Early-Onset Gout. Toyoda Y; Pavelcová K; Bohatá J; Ješina P; Kubota Y; Suzuki H; Takada T; Stiburkova B Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33669292 [TBL] [Abstract][Full Text] [Related]
3. Cellular Processing of the ABCG2 Transporter-Potential Effects on Gout and Drug Metabolism. Mózner O; Bartos Z; Zámbó B; Homolya L; Hegedűs T; Sarkadi B Cells; 2019 Oct; 8(10):. PubMed ID: 31597297 [TBL] [Abstract][Full Text] [Related]
5. The Role of ABCG2 in the Pathogenesis of Primary Hyperuricemia and Gout-An Update. Eckenstaler R; Benndorf RA Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34206432 [TBL] [Abstract][Full Text] [Related]
6. ABCG2 as a therapeutic target candidate for gout. Fujita K; Ichida K Expert Opin Ther Targets; 2018 Feb; 22(2):123-129. PubMed ID: 29264928 [TBL] [Abstract][Full Text] [Related]
7. The impact of dysfunctional variants of ABCG2 on hyperuricemia and gout in pediatric-onset patients. Stiburkova B; Pavelcova K; Pavlikova M; Ješina P; Pavelka K Arthritis Res Ther; 2019 Mar; 21(1):77. PubMed ID: 30894219 [TBL] [Abstract][Full Text] [Related]
8. Genetic polymorphisms and decreased protein expression of ABCG2 urate transporters are associated with susceptibility to gout, disease severity and renal-overload hyperuricemia. Pálinkás M; Szabó E; Kulin A; Mózner O; Rásonyi R; Juhász P; Nagy K; Várady G; Vörös D; Zámbó B; Sarkadi B; Poór G Clin Exp Med; 2023 Aug; 23(4):1277-1284. PubMed ID: 35939175 [TBL] [Abstract][Full Text] [Related]
9. The ABCG2 Q141K hyperuricemia and gout associated variant illuminates the physiology of human urate excretion. Hoque KM; Dixon EE; Lewis RM; Allan J; Gamble GD; Phipps-Green AJ; Halperin Kuhns VL; Horne AM; Stamp LK; Merriman TR; Dalbeth N; Woodward OM Nat Commun; 2020 Jun; 11(1):2767. PubMed ID: 32488095 [TBL] [Abstract][Full Text] [Related]
10. Pleiotropic effect of the ABCG2 gene in gout: involvement in serum urate levels and progression from hyperuricemia to gout. Wrigley R; Phipps-Green AJ; Topless RK; Major TJ; Cadzow M; Riches P; Tausche AK; Janssen M; Joosten LAB; Jansen TL; So A; Harré Hindmarsh J; Stamp LK; Dalbeth N; Merriman TR Arthritis Res Ther; 2020 Mar; 22(1):45. PubMed ID: 32164793 [TBL] [Abstract][Full Text] [Related]
11. Clinically relevant mutations in the ABCG2 transporter uncovered by genetic analysis linked to erythrocyte membrane protein expression. Zámbó B; Bartos Z; Mózner O; Szabó E; Várady G; Poór G; Pálinkás M; Andrikovics H; Hegedűs T; Homolya L; Sarkadi B Sci Rep; 2018 May; 8(1):7487. PubMed ID: 29749379 [TBL] [Abstract][Full Text] [Related]
12. Identification of a urate transporter, ABCG2, with a common functional polymorphism causing gout. Woodward OM; Köttgen A; Coresh J; Boerwinkle E; Guggino WB; Köttgen M Proc Natl Acad Sci U S A; 2009 Jun; 106(25):10338-42. PubMed ID: 19506252 [TBL] [Abstract][Full Text] [Related]
13. Trans-ancestral dissection of urate- and gout-associated major loci SLC2A9 and ABCG2 reveals primate-specific regulatory effects. Takei R; Cadzow M; Markie D; Bixley M; Phipps-Green A; Major TJ; Li C; Choi HK; Li Z; Hu H; ; Guo H; He M; Shi Y; Stamp LK; Dalbeth N; Merriman TR; Wei WH J Hum Genet; 2021 Feb; 66(2):161-169. PubMed ID: 32778763 [TBL] [Abstract][Full Text] [Related]
14. The ABCG2/BCRP transporter and its variants - from structure to pathology. Sarkadi B; Homolya L; Hegedűs T FEBS Lett; 2020 Dec; 594(23):4012-4034. PubMed ID: 33015850 [TBL] [Abstract][Full Text] [Related]
15. Epistatic interaction between PKD2 and ABCG2 influences the pathogenesis of hyperuricemia and gout. Dong Z; Zhou J; Jiang S; Li Y; Zhao D; Yang C; Ma Y; He H; Ji H; Jin L; Zou H; Wang J Hereditas; 2020 Jan; 157(1):2. PubMed ID: 32000861 [TBL] [Abstract][Full Text] [Related]
16. The prevalence of the gout-associated polymorphism rs2231142 G>T in ABCG2 in a pregnant female Filipino cohort. Roman Y; Tiirikainen M; Prom-Wormley E Clin Rheumatol; 2020 Aug; 39(8):2387-2392. PubMed ID: 32107664 [TBL] [Abstract][Full Text] [Related]
17. Identification of ABCG2 dysfunction as a major factor contributing to gout. Matsuo H; Takada T; Ichida K; Nakamura T; Nakayama A; Takada Y; Okada C; Sakurai Y; Hosoya T; Kanai Y; Suzuki H; Shinomiya N Nucleosides Nucleotides Nucleic Acids; 2011 Dec; 30(12):1098-104. PubMed ID: 22132963 [TBL] [Abstract][Full Text] [Related]
18. Gout-causing Q141K mutation in ABCG2 leads to instability of the nucleotide-binding domain and can be corrected with small molecules. Woodward OM; Tukaye DN; Cui J; Greenwell P; Constantoulakis LM; Parker BS; Rao A; Köttgen M; Maloney PC; Guggino WB Proc Natl Acad Sci U S A; 2013 Mar; 110(13):5223-8. PubMed ID: 23493553 [TBL] [Abstract][Full Text] [Related]
19. [ROLE OF SLC2A9 AND ABCG2 GENE POLYMORPHISMS IN ORIGIN OF HYPERURICEMIA AND GOUT]. Fadieieva A; Prystupa L; Pogorelova O; Kirichenko N; Dudchenko I Georgian Med News; 2016 Mar; (252):79-83. PubMed ID: 27119840 [TBL] [Abstract][Full Text] [Related]
20. Functional non-synonymous variants of ABCG2 and gout risk. Stiburkova B; Pavelcova K; Zavada J; Petru L; Simek P; Cepek P; Pavlikova M; Matsuo H; Merriman TR; Pavelka K Rheumatology (Oxford); 2017 Nov; 56(11):1982-1992. PubMed ID: 28968913 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]